Winston Kung

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Winston Kung
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Winston Kung:

Form 4 holding COO, CFO

PMV Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
150,000
Estimated value
Report date
12 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

ArriVent BioPharma, Inc.

Security class
Stock Option (right to buy)
Shares / value
140,000
Estimated value
Report date
02 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Winston Kung

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .